SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-758835
Filing Date
2016-11-03
Accepted
2016-11-03 16:13:04
Documents
53
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d172494d10q.htm 10-Q 710177
2 EX-31.1 d172494dex311.htm EX-31.1 8464
3 EX-31.2 d172494dex312.htm EX-31.2 8435
4 EX-32.1 d172494dex321.htm EX-32.1 2823
5 EX-32.2 d172494dex322.htm EX-32.2 2780
  Complete submission text file 0001193125-16-758835.txt   3621799

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT agio-20160930.xml EX-101.INS 603592
7 XBRL TAXONOMY EXTENSION SCHEMA agio-20160930.xsd EX-101.SCH 41979
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE agio-20160930_cal.xml EX-101.CAL 45775
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE agio-20160930_def.xml EX-101.DEF 136934
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE agio-20160930_lab.xml EX-101.LAB 351842
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE agio-20160930_pre.xml EX-101.PRE 241842
Mailing Address 38 SIDNEY STREET 2ND FLOOR CAMBRIDGE MA 02139
Business Address 38 SIDNEY STREET 2ND FLOOR CAMBRIDGE MA 02139 617-272-5275
AGIOS PHARMACEUTICALS INC (Filer) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36014 | Film No.: 161971729
SIC: 2834 Pharmaceutical Preparations